These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1285 related articles for article (PubMed ID: 7682562)

  • 21. An elevation of serum immunoglobulin E provides a new aspect of hyperthyroid Graves' disease.
    Yamada T; Sato A; Komiya I; Nishimori T; Ito Y; Terao A; Eto S; Tanaka Y
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2775-8. PubMed ID: 10946880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
    Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
    N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pituitary-thyroid feedback regulation in patients with Graves' disease during antithyroid drug therapy.
    Yamada T; Takasu N; Sato A; Aizawa T; Koizumi Y
    J Clin Endocrinol Metab; 1982 Jan; 54(1):83-8. PubMed ID: 6798061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study. The European Multicentre Trial Group of the Treatment of Hyperthyroidism with Antithyroid Drugs.
    Benker G; Reinwein D; Kahaly G; Tegler L; Alexander WD; Fassbinder J; Hirche H
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):451-7. PubMed ID: 9876342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents.
    Wood LC; Ingbar SH
    J Clin Invest; 1979 Nov; 64(5):1429-36. PubMed ID: 91625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma free triiodothyronine response to thyrotropin-releasing hormone to predict the remission of Graves' disease treated with antithyroid drugs.
    Notsu K; Oka N; Masaki Y; Furuya H; Kato Y
    J Clin Endocrinol Metab; 1991 Aug; 73(2):396-400. PubMed ID: 1713218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Similar effects of thionamide drugs and perchlorate on thyroid-stimulating immunoglobulins in Graves' disease: evidence against an immunosuppressive action of thionamide drugs.
    Wenzel KW; Lente JR
    J Clin Endocrinol Metab; 1984 Jan; 58(1):62-9. PubMed ID: 6196375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Studies on the TRH test on the patients with Graves' disease during the treatment with antithyroid drug (author's transl)].
    Enomoto K; Inoue K; Enomoto H
    Nihon Naibunpi Gakkai Zasshi; 1975 Dec; 51(12):1052-64. PubMed ID: 823053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease.
    Takamatsu J; Hosoya T; Naito N; Yoshimura H; Kohno Y; Tarutani O; Kuma K; Sakane S; Takeda K; Mozai T
    J Clin Endocrinol Metab; 1988 Jan; 66(1):147-52. PubMed ID: 3335601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyroid function and intellectual development of infants nursed by mothers taking methimazole.
    Azizi F; Khoshniat M; Bahrainian M; Hedayati M
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3233-8. PubMed ID: 10999814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyrotropin receptor autoantibodies are associated with continued thyrotropin suppression in treated euthyroid Graves' disease patients.
    Brokken LJ; Wiersinga WM; Prummel MF
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4135-8. PubMed ID: 12970276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of iodine upon the TRH induced release of TSH in euthyroid, hypothyroid and hyperthyroid individuals.
    Waldhäusl W; Haydl H
    Horm Metab Res; 1976 Jul; 8(4):286-91. PubMed ID: 821840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of l-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study.
    Glinoer D; de Nayer P; Bex M;
    Eur J Endocrinol; 2001 May; 144(5):475-83. PubMed ID: 11331213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
    Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
    Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid response, especially to thyrotropin-binding inhibitory immunoglobulins, in euthyroid relatives of patients with Graves' disease: a clinical follow-up.
    Tamai H; Kasagi K; Morita T; Hidaka A; Kuma K; Konishi J; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1990 Jul; 71(1):210-5. PubMed ID: 1973421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study.
    Andrade VA; Gross JL; Maia AL
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3488-93. PubMed ID: 11502768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
    Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
    Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short and long term effects of radioiodine treatment on the iodine content of the thyroid gland.
    Schlumberger M; Fragu P; Hill C; Parmentier C; Tubiana M
    J Clin Endocrinol Metab; 1984 Nov; 59(5):893-8. PubMed ID: 6548226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperthyroidism caused by a pituitary thyrotrophin-secreting tumour with excessive secretion of thyrotrophin-releasing hormone and subsequently followed by Graves' disease in a middle-aged woman.
    Kamoi K; Mitsuma T; Sato H; Yokoyama M; Washiyama K; Tanaka R; Arai O; Takasu N; Yamada T
    Acta Endocrinol (Copenh); 1985 Nov; 110(3):373-82. PubMed ID: 3934894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of methimazole, methimazole and sodium ipodate, and methimazole and saturated solution of potassium iodide in the early treatment of hyperthyroid Graves' disease.
    Roti E; Robuschi G; Gardini E; Montermini M; Salvi M; Manfredi A; Gnudi A; Braverman LE
    Clin Endocrinol (Oxf); 1988 Mar; 28(3):305-14. PubMed ID: 3168311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 65.